Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma

Immune escape mechanisms and immunotherapy of urothelial bladder cancer

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial

Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy

A Bayesian network meta-analysis of comparison of cancer therapeutic vaccines for melanoma

Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications

Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities

A phase I study to evaluate the safety and effectiveness of neoantigen-based personalized dendritic cell vaccine in patients with advanced solid tumors.

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma

Recent Progress in Dendritic Cell-Based Cancer Immunotherapy